Key Details
Catalog |
MAS-0124-YJ25 |
Applications |
ELISA |
Host |
Human |
Reactivity |
B. mallei |
Clonality |
Monoclonal |
Conjugations |
Conjugation could be customized |
Overview
Properties
Target
Related Products
Overview
Description
|
Clones cMF5 and cMF6 are Chimeric (mouse/human) IgG1 kappa recognize B. mallei. They were expressed in mammalian cells with mouse variable regions and human constant regions.
|
Reactivity
|
B. mallei
|
Applications
|
ELISA
|
Host
|
Human
|
Isotype
|
cMF5 & cMF6: Human IgG1 kappa
|
Clonality
|
Monoclonal
|
Clone
|
cMF5; cMF6
|
Dilutions
|
ELISA: 0.1-1000 ng/mL
|
Properties
Expression Host
|
HEK293F/CHO
|
Conjugations
|
Conjugation could be customized
|
Purification
|
Protein A/G affinity purified is the regular method
|
Purity
|
SDS-PAGE> 95%
|
Endotoxin Level
|
Endotoxin level could be customized
|
Form
|
Liquid (frequently-used) or lyophilized
|
Concentration
|
About 1mg/ml. There are differences between batches. Special concentration could be customized.
|
Sterility
|
0.2 μM filtered
|
Buffer
|
See the Datasheet
|
Storage
|
See the Datasheet
|
Target
Target
|
B. mallei LPS
|
Alternative Names
|
LPS; Lipopolysaccharides; Burkholderia mallei; B. mallei
|
Introduction
|
Burkholderia mallei is a Gram-negative, bipolar, aerobic bacterium, a Burkholderia-genus human and animal pathogen causing glanders; the Latin name of this disease (malleus) gave its name to the species causing it. It is closely related to B. pseudomallei, and by multilocus sequence typing it is a subspecies of B. pseudomallei.
|
Organism
|
Bacteria
|
Related Disease
|
Glanders disease
|
Infections Route
|
Cutaneous; Inhalation; Gastrointestinal; Injection
|